As new COVID-19 cases plunge across the country and states roll back virus-related restrictions, there are still strong concerns about an omicron subvariant. Medical experts are keeping a close eye on it, fearing it could lead to yet another surge in cases.
A new spinoff of the omicron coronavirus variant is catching some attention, as it is becoming the dominant cause of COVID-19 in some parts of the world.
On average, new cases of COVID-19 are down 39% from the omicron peak. Hospitalizations in many states are falling too.
Health officials are tracking a new sub-variant of omicron that’s already been reported in at least 55 countries, including dozens of cases in states across the U.S. Some call it “stealth omicron” because of a unique feature that may make it harder to detect.
While cases are still increasing, Dr. Traxler says they are increasing at a slower rate. However, there is one trend that does have her concerned.
Pfizer says it is testing an omicron-specific vaccine booster. This comes as the FDA faces backlash over its decision to halt the use of two antibody treatments.
As some hospitals continue feeling the strain from the omicron variant, there is some encouraging news. Dr. Anthony Fauci says this surge may be just three weeks from its peak.
Dr. Fauci says the fight against omicron is going in the right direction, but hospitals in many parts of the country are still overwhelmed.
While the same can’t be said for the Palmetto State, cases of the omicron variant are leveling off or even decreasing in at least 12 states. Health experts warn that we haven’t turned the corner just yet.
The U.S. surgeon general is warning of a tough few weeks ahead, as the omicron variant spreads fast across the country. There are signs of hope, with new cases declining in some notoriously hotspot areas.
